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Abstract
Background: In mammals, the dynamics of DNA methylation, in particular the regulated, active removal of cytosine 
methylation, has remained a mystery, partly due to the lack of appropriate model systems to study DNA 
demethylation. Previous work has largely focused on proliferating cell types that are mitotically arrested using 
pharmacological inhibitors to distinguish between active and passive mechanisms of DNA demethylation.
Results: We explored this epigenetic phenomenon in a natural setting of post-mitotic cells: the differentiation of 
human peripheral blood monocytes into macrophages or dendritic cells, which proceeds without cell division. Using a 
global, comparative CpG methylation profiling approach, we identified many novel examples of active DNA 
demethylation and characterized accompanying transcriptional and epigenetic events at these sites during monocytic 
differentiation. We show that active DNA demethylation is not restricted to proximal promoters and that the time-
course of demethylation varies for individual CpGs. Irrespective of their location, the removal of methylated cytosines 
always coincided with the appearance of activating histone marks.
Conclusions: Demethylation events are highly reproducible in monocyte-derived dendritic cells from different 
individuals. Our data suggest that active DNA demethylation is a precisely targeted event that parallels or follows the 
modification of histones, but is not necessarily coupled to alterations in transcriptional activity.
Background
The methylation of cytosine in the context of CpG dinu-
cleotides in mammalian DNA is generally associated with
gene silencing. The controlled setting and removal of
DNA methylation are crucial for proper execution of
essential regulatory programs in embryonic develop-
ment, X-chromosome inactivation, parental imprinting
as well as cellular differentiation [1-4]. Altered levels of
cytosine methylation are associated with various diseases
and may promote neoplastic development [5,6].
Whereas the process of DNA methylation, which is cat-
alyzed by a group of DNA methyltransferases (DNMTs) is
well characterized [7,8], the mechanisms responsible for
the removal of methylated cytosines are less well under-
stood. The failure of maintenance DNMTs to methylate a
newly synthesized daughter strand during cell cycle pro-
gression represents a non-enzymatic, passive way of eras-
ing the 5-methylcytosine mark that requires at least two
cycles of replication for complete DNA demethylation.
The documented existence of replication-independent
DNA demethylation processes implies the presence of
demethylating enzymes that actively remove either the
methyl group, the methylated cytosine or whole nucle-
otides [9]. In flowering plants, the enzymes driving the
active demethylation process are well known. DME
(Demeter) and ROS1  (Repressor of silencing 1) are 5-
methylcytosine glycosylases/lyases [10-12] that catalyze
the first step of an active demethylation process that is
linked to base excision repair. In animal cells, DNA dem-
ethylation through DNA repair mechanisms was first
described by Jost and colleagues [13], who reported evi-
dence for an enzymatic system replacing 5-methylcyto-
sine by cytosine. Nuclear extracts from chicken embryos
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promoted demethylation of selective mCpGs in hemim-
ethylated DNA through the formation of specific nicks 5'
of 5-methyldeoxycytidine [13]. The responsible enzyme
was later identified as a thymine DNA glycosylase [14].
Recently, it was shown that loss of methylation at an
estrogen-responsive element coincides with the recruit-
ment of DNMT3a/b, thymine DNA glycosylase and other
base excision repair enzymes, confirming the implication
of base excision repair [15]. The authors of the latter
study assigned deaminating activities to both DNMTs;
however, the involvement of DNMTs in catalyzing cyto-
sine deamination remains controversial [9,16]. Another
recent study showed that the hormone-regulated DNA
demethylation of a gene promoter is mediated by glycosy-
lase activity of MBD4 (methyl-CpG binding domain pro-
tein 4), another thymine glycosylase involved in removing
T/G mismatches [17].
Most studies in the field of active DNA demethylation
are based on cell models that normally proliferate, includ-
ing pharmacologically arrested cell lines, primordial germ
cells, and zebrafish or Xenopus laevis embryos, and this
property is often utilized to argue in favor of passive
mechanisms as a basis for the observed demethylation
events.
In this study, the differentiation of human peripheral
blood monocytes to immature dendritic cells (DCs) was
used to analyze active demethylation processes. Periph-
eral blood monocytes are non-dividing progenitors of the
mononuclear phagocyte system that are able to differen-
tiate into morphologically and functionally divergent
effector cells, including antigen presenting DCs, mac-
rophages or osteoclasts [18]. Due to their proliferation-
independent differentiation, human monocytes represent
an excellent model to study active DNA demethylation.
Global promoter experiments and fine-mapping studies
revealed a considerable number of targeted, active dem-
ethylation events during monocyte to DC differentiation
that were neither restricted to promoter regions nor gen-
erally associated with transcriptional changes. Irrespec-
tive of their genomic localization, DNA demethylation
always coincided with the appearance of activating his-
tone marks, suggesting a close association of chromatin
modifying complexes with the DNA demethylation
machinery.
Results
Differentiation of monocytes into myeloid dendritic cells 
occurs in the absence of proliferation
Peripheral blood monocytes are characterized by a
unique phenotypic plasticity and are able to differentiate
into a number of morphologically and functionally
diverse cell types in vivo, including the wide range of het-
erogeneous tissue macrophages, myeloid DCs and multi-
nucleated osteoclasts. The distinct differentiation
pathways can be recapitulated in vitro: culturing purified
human monocytes for several days in the presence of
human serum results in the generation of macrophages
(Figure 1a), whereas they develop into myeloid DCs in the
presence of the granulocyte-macrophage colony-stimu-
lating factor and IL-4 [19]. Both cell types are character-
Figure 1 Postproliferative differentiation model. (a) Schematic 
presentation of the culture system. After leukapheresis and subse-
quent elutriation, monocytes (MO) were cultured either in the pres-
ence of IL-4, granulocyte-macrophage colony-stimulating factor (GM-
CSF) and FCS to generate DCs or with human AB-serum to obtain mac-
rophages (MAC) for 7 days. (b) Microarray expression profiles of several 
marker genes that are preferentially expressed in macrophages 
(CHI3L1, CHIT1), monocytes (KLF4, FOSB) or DCs (CD1A, CCL17) and con-
trol genes (VDR, SPI1) showing constant mRNA levels during differenti-
ation. Shown are median-normalized microarray signal intensities 
derived from ten (monocytes) or six (DCs and macrophages) indepen-
dent donors. (c) DCs and U937 cells were cultured with [3H]-thymidine 
for 20 h at different time points (day 0 to 1, day 1 to 2, day 2 to 3, day 3 
to 4) during culture. Values represent mean ± standard deviation of 
three independent experiments. The U937 leukemia cell line served as 
positive control showing high thymidine incorporation levels.
blood monocyte (MO)
macrophage (MAC)
AB
7d
IL-4
GM-CSF
FCS
7d
immature dendritic cell (DC)
0.01
0.1
1
10
100
1000 CHI3L1
CHIT1
0.1
1
10
100
1000
10000 CD1A
CCL17
0.01
0.1
1
10
100
1000
KLF4
FOSB
0.1
1
10
100
1000
VDR
SPI1
DC
MO
MAC
DC
MO
MAC
Relative
mRNA
Expression
[
H
]Thymidine
incorporation
3
(cpm/100,000
cells/24h)
(a)
(b)
1
10
100
1000
10000
100000
1000000
medium
DC
U937
(c)
d 0-d 1 d 1-d 2 d 2-d 3 d 3-d 4
Treatment timeKlug et al. Genome Biology 2010, 11:R63
http://genomebiology.com/2010/11/6/R63
Page 3 of 11
ized by a unique transcriptome (examples of marker gene
expression are shown in Figure 1b) and their develop-
ment from primary monocytes proceeds without cell
division [20,21]. To confirm the absence of proliferation-
dependent or -independent DNA synthesis, we measured
the incorporation of [3H]-thymidine during the first 4
days of monocyte to DC differentiation. As shown in Fig-
ure 1c, we did not detect significant nucleotide incorpo-
ration during the analyzed time period. Similar results
were obtained using 5-Bromo-2'-deoxy-uridine (BrdU)
incorporation and subsequent immunostaining (Figure
S1 in Additional file 1). In line with several earlier studies
[22,23,25], proliferative activity ranged between 0 and 2%
during the first 3 days of culture depending on the donor.
Differentiating monocytes thus present an ideal post-
mitotic cellular model to study epigenetic processes.
Global identification of differentially methylated regions in 
dendritic cells and macrophages
In order to assess occurrence and extent of active DNA
demethylation during monocytic differentiation, we per-
formed genome-wide methylation analyses using methyl-
CpG immunoprecipitation (MCIp), a fractionation tech-
nique that is based on the salt concentration-dependent
affinity of methylated and non-methylated DNA frag-
ments towards an MBD-Fc fusion protein [26,27]. We
refined and adapted the MCIp approach (schematically
shown in Figure S2A in Additional file 1) for global pro-
moter methylation analyses as recently described [28].
DNA samples from in vitro-differentiated monocyte-
derived macrophages and DCs were separated into meth-
ylated (mCpG) and unmethylated (CpG) pools via MCIp
(Figure S2B in Additional file 1; two biological replicates).
Cell type-specific differences in the DNA methylation
pattern were then identified by co-hybridization of either
both hypermethylated or both hypomethylated DNA
subpopulations to custom-designed 244 K human pro-
moter oligonucleotide arrays (Figure 2) covering 5-kb
regions around 17,000 known promoters of protein-cod-
ing genes. DNA fragments enriched in the methylated
fraction of a given cell type are depleted in the corre-
sponding unmethylated fraction. Therefore, the signal
intensities in CpG pool and mCpG pool hybridizations
complement each other ('mirror-image' approach; Figure
2; Figure S2 in Additional file 1) and allow the identifica-
tion of differentially methylated regions (DMRs). In total,
the microarray analyses revealed 45 regions that were
h y p o m e t h y l a t e d  i n  DC s  c o m p a r e d  t o  m a c r o p h a g e s .  I n
line with previous findings, most DMRs were of low CpG
content and all residual sites were of intermediate CpG
content (data not shown). To validate and quantify meth-
ylation differences, 28 representative regions (including
21 DMRs, 6 control regions selected from array results
and one additional region) were selected for matrix-
assisted laser desorption/ionisation-time of flight
(MALDI-TOF) mass spectrometry (MS) analysis of
bisulfite-treated DNA (for information on amplicons and
MALDI-TOF MS results for all samples see Additional
files 2 and 3). In total, 22 out of 25 regions detected with
b o t h  a s s a y s  ( 8 8 % )  w e r e  c o n c o r d a n t  b e t w e e n  M C I p -
microarray and MALDI TOF MS data. Figure 3 and Fig-
ure S3 in Additional file 1 show several examples for the
high consistency of both approaches. Classical bisulfite-
sequencing experiments of three representative regions
also confirmed the targeted and reproducible demethyla-
tion of defined CpG residues in DCs (Figure S4 in Addi-
t i o n a l  f i l e  1 ) .  A n  a n n o t a t e d ,  c o m p l e t e  l i s t  o f  D M R s  i s
given in Figure 4, which also provides the position of each
DMR relative to the transcription start site (TSS) of
neighboring genes, local CpG/GC content, as well as cor-
responding mRNA expression data. Interestingly, DMRs
were always methylated in monocytes, indicating that all
observed methylation differences resulted from demethy-
lation. We did not observe a single case of differentiation-
associated de novo DNA methylation. Thus, most (if not
all) DMRs are actively demethylated during DC differen-
tiation.
Figure 2 Identification of differentially DNA methylated regions. 
The fragmented genomes of macrophages (MAC) and immature den-
dritic cells (iDC) are separated into unmethylated (CpG) and methylat-
ed (mCpG) pools. Each pool is directly labeled using fluorescent dyes 
and each pool of one cell type is compared to the corresponding pool 
of the other cell type on a global promoter microarray. Microarray im-
ages are analyzed in combination to identify regions that show a recip-
rocal hybridization behavior. Representative scatter plots of CpG and 
mCpG pool hybridizations are shown. Probes enriched in the unmeth-
ylated pool of iDCs (red spots) were enriched in the methylated pool 
of macrophages (blue spots) and indicated the presence of DNA meth-
ylated regions. The reciprocal signal intensity ratios served as internal 
control for the reliability of microarray data.
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Active demethylation is targeted, not confined to proximal 
promoters and frequently but not imperatively linked with 
changes in transcription levels
The positional annotation of DMRs in Figure 4 demon-
strates that active demethylation processes were not lim-
ited to proximal promoter regions. Regardless of genomic
localization, demethylation of DMR proceeded in a
highly reproducible fashion during monocyte differentia-
tion using cells from several different individuals, as
exemplified by the promoter-proximal CCL13 DMR, the
promoter-distal, intergenic CD207  DMR and the
intragenic CLEC10A DMR in Figure S5 in Additional file
1. The high reproducibility between different donors sug-
gests that active CpG demethylation is a strictly targeted,
non-random event. Furthermore, active DNA demethyla-
tion processes did not proceed synchronously during
monocyte to DC development, with some CpGs being
demethylated early (between 18 and 42 h) and others
considerably later (> 51 h) (Figure S5 in Additional file 1
and data not shown). Most DMRs contained CpGs that
were demethylated during the first 51 h, a period during
which we never observed significant proliferation of DCs.
The reproducibility of CpG demethylation and the pres-
ence of DMR-specific demethylation kinetics suggest
sequence-specific targeting mechanisms that are likely
mediated through DNA-binding factors either directly or
indirectly.
We also correlated the presence of DMR with mRNA
expression data obtained by whole genome microarray
analyses of monocyte differentiation time courses (three
biological replicates). As shown in Figure 4, about half of
the DMR-associated genes were up-regulated during
monocyte to DC differentiation. As a prime example for
active demethylation at a proximal promoter, the CCL13
DMR was studied in more detail as shown in Additional
file 1 (detailed characterization of the CCL13 promoter
and Figure S6). The data suggest that CpG methylation in
this particular case may contribute to transcription
repression by preventing the binding of a yet unknown
nuclear factor and that active demethylation at this site
may be necessary for high level transcription in DCs.
However, a correlation between demethylation and
increased transcription was not universally observed as
t r a n s c r i p t i o n  l e v e l s  o f  m a n y  D M R - a s s o c i a t e d  g e n e s
remained largely unchanged during differentiation, as
measured by microarray analysis. Increases in gene
expression at demethylated genes also did not correlate
with the local CpG or GC content, which was not signifi-
cantly different between both groups of genes (P > 0.1,
Mann Whitney U-test).
Active DNA demethylation coincides with the appearance 
of active histone marks
Previous studies in other systems suggested a strong link
between lineage-specific CpG demethylation events and
changes in activating histone marks, including histone
H3 lysine 4 (H3K4) methylation [28-30]. Since the above
studies were done in proliferating cells, it was unclear
whether the observed demethylation processes were
active or passive. To determine whether similar correla-
tions exist in a setting of post-proliferative monocytes
that can only actively demethylate cytosine residues, we
Figure 3 Comparison of MCIp microarray and MassARRAY EpiTYPER data. (a-c) Diagrams at the top show signal ratios of microarray probes for 
both independent experiments (donor A in blue, donor B in red) corresponding to their chromosomal localization. Typical DMRs are enriched in the 
hypomethylated fraction of one cell type and in the hypermethylated region of the other one, resulting in a mirror inverted image. Orange-colored 
zones indicate sequence regions validated via bisulfite conversion. Middle panels schematically present the chromosomal location of DMRs (orange 
boxes). Regions analyzed by MALDI TOF MS of bisulfite-converted DNA are indicated at the bottom. White circles represent detectable CpGs while 
grey circles (or grey boxes in the heat map below) show CpGs not measured by MS. Heat maps depict the methylation status of individual CpGs as 
shades of blue with each box representing a single CpG. Data of at least six independent donors were averaged.
MAC
MO
DC
CLEC10A
MAC
MO
DC
CCL13 CCL1
MAC
MO
DC
STAT5A STAT5B
12345 123456789 1 0 1 11 21 31 4 0
|
20
|
40
|
60
|
80
|
100
|
1234567
0.2
1
5
DC/MAC
signal
ratio
Hypo Exp.A
Hyper Exp.A
Hypo Exp.B
Hyper Exp.B
(a)
0.2
1
5
DC/MAC
signal
ratio
(b) (c)
200 bp 200 bp
0.2
1
5
DC/MAC
signal
ratio
200 bp
CpG methylation (%)Klug et al. Genome Biology 2010, 11:R63
http://genomebiology.com/2010/11/6/R63
Page 5 of 11
Figure 4 mRNA expression profiles of genes associated with DMRs during DC differentiation. Microarray expression levels of genes showing 
DC-specific CpG demethylation are displayed as a heat map. Blue, white and red represent low, medium and high expression, respectively. Data of 
two (DC day 7), three (DC 6 to 66 h) or six monocyte (MO) independent donors were averaged and normalized to monocyte samples. Distances from 
transcription start sites (TSSs) of neighboring genes, chromosomal locations (NCBI build 35/hg17) of the central DMR microarray probes and CpG as 
well as GC content in a 500-bp window are given on the right.
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performed chromatin immunoprecipitation (ChIP) time
course experiments studying the dynamics of histone
modifications at selected DMRs, representative of the
three possible genomic positions relative to the TSS
(proximal promoter/intergenic/intragenic). As shown in
F i gu r e  5 a  a n d  F i g u r e  S 7  i n  A d d i t i o n a l  f i l e  1 ,  a l l  s ev e n
actively demethylated regions tested exhibited increased
H3K4 methylation or H3/4 acetylation during differentia-
tion. As expected, H3K4 trimethylation was exclusively
measured close to transcription start sites (CCL13,
CLEC10A, DNASE1L3, P2RY6), whereas promoter-distal
sites only acquired H3K4 mono- and dimethylation,
which represents a signature indicative of putative
enhancers [31].
We next asked whether promoter-distal DMRs display
enhancer activity. Properties of generic enhancers include
their ability to increase transcriptional activity in a heter-
ologous context, which can be studied using traditional
reporter gene assays. We recently developed a reporter
vector that completely lacks CpG dinucleotides [32] and
utilized this system to test for heterologous enhancer
activity of seven selected DMRs (STAT5A, CD207, CBR3,
ADPGK, RAP1GAP, ALKBH5, RPS3A) that are located in
intergenic areas (between -4,700 to -1,100 bp from the
nearest TSS). Transient transfections were performed in
untreated, myeloid THP-1 cells using unmethylated
(CpG) or in vitro SssI-methylated (mCpG) reporter plas-
mids. STAT5A, CBR3, ALKBH5 and RPS3A fragments did
not show enhancer activity in THP-1 cells (data not
shown), which may relate to the fact that this cell line
lacks DC-specific transcriptional regulators. As shown in
Figure 5b, the remaining regions (ADPGK, CD207,
RAP1GAP) significantly enhanced the activity of the
basal (CpG-free) EF1 promoter and completely lost
enhancer activity when methylated, suggesting that their
enhancing activity is critically dependent on their CpG
methylation status.
Discussion
Despite the fact that numerous reports have described
active DNA demethylation, its existence in humans is still
controversial [16]. With few exceptions, previous studies
were performed in artificial cell systems such as (pharma-
cologically arrested) cell lines [15,33] or embryonic cells
[34,35], thus not entirely excluding a passive mechanism
underlying the observed CpG demethylation. In contrast,
human primary monocytes undergo differentiation into
functionally different effector cells in the absence of DNA
synthesis [20-25,36]. Consequently, in this post-mitotic
differentiation model, any loss of CpG methylation
observed must be the result of an active demethylation
process.
We have adapted our previously developed compara-
tive methylation profiling technology (MCIp) [26-28,37]
to perform a systematic global screen for actively dem-
ethylated regions utilizing a promoter-based tiling
microarray platform. This approach identified many
novel loci that undergo active demethylation. Subsequent
Figure 5 Functional analyses of DMRs. (a) Analysis of histone modifications across DMRs using ChIP. Chromatin was prepared at the indicated time 
points and precipitated against monomethyl histone H3 lysine 4 (H3K4me1), dimethyl histone H3 lysine 4 (H3K4me2) and trimethyl histone H3 lysine 
4 (H3K4me3) as well as against acetylated histones H3 and H4 (AcH3 and AcH4). The IgG background level is indicated by the violet line. DNA enrich-
ment of the indicated time points is normalized to 5% input DNA and shown relative to monocyte (0 h) enrichment. Data represent mean values ± 
standard deviation of at least three independent ChIP experiments. (b) Selected regions were cloned upstream of a basic EF1 promoter into the CpG-
free luciferase vector pCpGL. The indicated plasmids were in vitro SssI-methylated (mCpG) or unmethylated (CpG) and transiently transfected into 
THP-1 cells. Luciferase activity was normalized against the activity of a co-transfected Renilla construct and mean values ± standard deviation (n = 3) 
are shown relative to the unmethylated pCpGL-EF1 construct. Asterisks indicate significant differences between methylated and unmethylated plas-
mids (*P < 0.05 and **P < 0.01, paired Student's t-test). RLU, relative light units.
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MS-based fine-mapping analysis of CpG methylation [38]
performed in monocytes, macrophages and DCs during
the time course of differentiation clearly confirmed the
results of our global screen, demonstrating that active
D N A  d e m e t h y l a t i o n  i s  a  s t r i c t l y  t a r g e t e d  p r o c e s s  w i t h
locus-specific kinetics being almost identical between all
individuals studied. As observed in proliferating cell sys-
tems [28-30], active demethylation events are predomi-
nantly found at promoter-distal sites, are linked with the
appearance of activating histone marks such as H3K4
methylation and in some cases harbor methylation-sensi-
tive enhancer activity. The striking concordance of dem-
ethylation-associated properties in mitotic and
postmitotic cell systems suggests that the active demethy-
lation machinery may contribute to DNA methylation
dynamics in both settings.
Although the observed DNA demethylation events
clearly point to active enzymatic processes, the underly-
ing mechanisms are not completely understood. Recent
work by other groups suggests an involvement of DNA
repair mechanisms in active DNA demethylation. Other
studies implicated DNMTs (as deaminases) [15] and base
excision repair enzymes [15,17]. However, the proposed
deaminating role of DNMTs remains controversial
[9,16,17], and inhibitors of DNMTs did not affect the
active DNA methylation process in our system (data not
shown). The T/G mismatch repair enzyme MBD4 exhib-
its increased repair activity for methylated cytosines after
hormone-induced phosphorylation and was shown to be
required for the hormone-dependent demethylation of
the CYP27B1 gene, suggesting that cytosine deamination
may not necessarily be required for demethylation [17].
Another study argued for a model in which the TATA box
binding protein-associated factor TAF12 recruits
Gadd45a (growth arrest and DNA-damage induced-a)
and the nucleotide excision repair machinery to promot-
ers, resulting in active DNA demethylation [39]. A gener-
alized role for TAF12 in our postmitotic system, however,
seems unlikely because demethylation events in differen-
tiating monocytes are not limited to promoters (where
TAF12 binding is usually detected). Gadd45 proteins, ini-
tially identified as stress-inducible factors implicated in
cell cycle arrest, DNA repair as well as apoptosis [40,41],
have repeatedly been implicated in linking DNA repair
mechanisms with DNA demethylation [36,42,43]. Work
by Rai and colleagues [36], for example, suggest that
GADD45 promotes the deamination of 5-methylcytosine
through activation-induced cytidine deaminase
(AICDA), which is followed by MBD4-dependent base
excision. A critical role for AICDA in active DNA dem-
ethylation was recently also demonstrated in the setting
of nuclear reprogramming and the generation of induced
pluripotent stem cells [44]. However, especially the in
vivo role of GADD45a in DNA demethylation was ques-
tioned by other studies [45,46]. In our model, GADD45
proteins are dynamically regulated during DC develop-
m e n t  ( F i g u r e  S 8  i n  A d d i t i o n a l  f i l e  1 )  w h e r e a s  AICDA
mRNA expression was observed neither in monocytes
nor during DC differentiation (data not shown). Global
mRNA expression analyses across the differentiation
time course additionally revealed DNA repair-associated
genes that are significantly regulated during DC develop-
ment (Figure S8 in Additional file 1). However, a func-
tional implication of those candidates in CpG
demethylation processes remains to be elucidated. So far,
we have been unable to detect the recruitment of thymine
DNA glycosylase or MBD4 to demethylated sites using
ChIP assays (data not shown). This may suggest that
repair processes related to DNA demethylation are differ-
ent from those associated with DNA damage. However,
this may also relate to the observed broad time frame (>
24 h) in which non-synchronized DNA demethylation
processes occur in culture. The fact that only few mono-
cytes actually undergo demethylation at a given time
point may prevent the detection of transient interactions
between demethylation machinery components and
DNA.
Although we are currently unable to provide a clear
molecular mechanism for the observed active DNA
methylation processes observed during DC differentia-
tion, our data reveal a number of novel and interesting
insights into the nature of this process. A common prop-
erty of all tested demethylated regions is the appearance
of activating histone marks, such as mono- and dimethy-
lation of H3K4 or acetylation of histones H3 and H4 (Fig-
ure 5a; Figure S7 in Additional file 1). The strict
association of DNA demethylation and histone marks
that are also found at enhancer elements [28] argue for
the recruitment of DNA-binding factors that direct his-
tone methyl- and/or acetyl-transferases to these sites.
This is also supported by our limited enhancer reporter
assays, where three out of seven tested regions displayed
methylation-sensitive enhancer activity in a myeloid cell
line. It is possible that the same factors responsible for the
modification of histones also recruit the DNA demethyla-
tion machinery. Since the setting of activating histone
marks in differentiating monocytes precedes or parallels
active DNA demethylation, the deposited marks may
themselves be recognized by histone code-reading pro-
teins associated with the DNA demethylation machinery.
Conclusions
We provide a first global screen for active DNA demethy-
lation and demonstrate that active DNA demethylation
during the differentiation of human monocytes is a
strictly targeted, highly reproducible process that is nei-
ther limited to promoter regions nor necessarily associ-
ated with detectable changes at the level of transcription.Klug et al. Genome Biology 2010, 11:R63
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Page 8 of 11
It is, however, tightly linked with 'activating' histone mod-
ifications, suggesting that the DNA demethylation
machinery may be recruited as part of other chromatin-
modifying processes associated with gene activation or
transcriptional priming.
Materials and methods
Ethics statement
Collection of blood cells from healthy donors was per-
formed in compliance with the Helsinki Declaration. All
donors signed an informed consent. Blood sampling, the
leukapheresis procedure and subsequent purification of
peripheral blood monocytes was approved by the local
ethical committee (reference number 92-1782 and 09/
066c).
Cells
Peripheral blood monocytes were separated by leuka-
pheresis of healthy donors followed by density gradient
centrifugation over Ficoll/Hypaque and subsequent
counter current centrifugal elutriation in a J6M-E centri-
fuge (Beckman Coulter GmbH, Krefeld, Germany) as
previously described [47]. Monocytes were > 85% pure as
determined by morphology and expression of CD14 anti-
gen. Supernatants of monocyte cultures were routinely
collected and analyzed for the presence of IL-6, which
was usually low, indicating that monocytes were not acti-
vated before or during elutriation. To generate immature
DCs, 1 × 106 monocytes/ml were cultured in RPMI 1640
medium (Thermo Scientific, Bonn, Germany) supple-
mented with 10% FCS (Biowhittaker, Verviers, Belgium),
20 U/ml IL-4 (Promokine, Heidelberg, Germany) and 280
U/ml granulocyte-macrophage colony-stimulating factor
(Berlex, Seattle, WA, USA). For generating macrophages,
1 × 106  monocytes/ml were seeded in RPMI 1640
medium (HyClone) supplemented with 2% human
pooled AB-group serum (Cambrex IEP GmbH, Wies-
baden, Germany) and cultured on teflon foils. THP-1
(human monocytic leukemia cell line) and U937 cells
(human leukemic monocyte lymphoma cell line) were
grown in RPMI 1640 plus 10% FCS (PAA, Pasching, Aus-
tria). RPMI 1640 was routinely enriched with 2 mM L-
glutamine (Biochrome, Berlin, Germany), MEM non-
essential amino acids (Invitrogen, Darmstadt, Germany),
sodium pyruvate (Invitrogen), MEM vitamins (Invitro-
gen), 50 U/ml penicillin/streptomycin (Invitrogen), and
50 nM 2-mercaptoethanol (Invitrogen). The human cer-
vical carcinoma cell line HeLa was maintained in Dul-
becco's modified Eagle's medium plus 10% FCS.
DNA isolation
Genomic DNA was prepared using the Blood and Cell
Culture Midi Kit from Qiagen (Hilden, Germany). DNA
concentration was determined with the ND-1000 Nano-
Drop spectrophotometer (Thermo Scientific, Bonn, Ger-
many) and quality was assessed by agarose gel
electrophoresis.
RNA isolation
Total cellular RNA was isolated using the RNeasy Mini
Kit (Qiagen). RNA concentration was measured with the
ND-1000 NanoDrop Spectrophotometer (Thermo Scien-
tific) and quality was controlled on agarose gels or using
the Agilent Bioanalyzer (Böblingen, Germany).
Whole genome expression analysis
Labeling, hybridization and scanning of high quality RNA
was performed using the Agilent microarray platform
according to the manufacturer's instructions. In brief, 200
to 1,000 ng of high-quality RNA were amplified and Cya-
nine 3-CTP-labelled with the One colour Low RNA Input
Linear Amplification Kit. Labeling efficiency was con-
trolled using the NanoDrop spectrophotometer and 1.65
μg labeled cRNA were fragmented and hybridized on
Whole Human Genome Expressionarrays (4 × 44 K Agi-
lent). Microarrays were washed and subsequently
scanned with an Agilent scanner. Raw data were
extracted with Feature Extraction 9.5.1 software and ana-
lyzed using GeneSpring GX 10.0.2 (Agilent). Data were
normalized to the 75th percentile and baseline-trans-
formed to the median of freshly isolated monocyte sam-
ples. Microarray data have been submitted and are
available from the National Center for Biotechnology
Information (NCBI) Gene Expression Omnibus (GEO)
repository (accession number [GEO:GSE19236]).
Chromatin immunoprecipitation
Preparation of cross-linked chromatin was performed as
described previously [48] with some modifications.
Briefly, cells were treated with 1% formaldehyde solution
for 7 minutes at room temperature and quenched by
0.125 M glycine. After washing with phosphate-buffered
saline including 1 mM phenylmethylsulfonylfluoride, 2 ×
106 cells were resuspended in 50 μl lysis buffer 1A (L1A:
10 mM HEPES/KOH pH 7.9, 85 mM KCl, 1 mM EDTA
pH 8.0) and lysed by adding 50 μl lysis buffer 1B (L1A +
1% Nonidet P-40) for 10 minutes on ice. Cross-linked
chromatin was sheared to an average DNA fragment size
around 400 to 600 bp using a Branson Sonifier 250 (Dan-
bury, CT, USA). After centrifugation, 4 μl of the lysate
were used as 5% input. After pre-clearing with 50 μl Sep-
harose CL-4B beads (blocked with 0.2% bovine serum
albumin and 5 μg sheared salmon sperm for 1 h at 4°C)
for 2 h, chromatin samples were immunoprecipitated
overnight with 2.5 μg rabbit anti-RNA polymerase II
CTD repeat YSPTSPS (phospho S5), anti-monomethyl
Histone H3 (Lys4) (ab5131, ab8895, respectively; Abcam,
Cambridge, UK), anti-dimethyl-Histone H3 (Lys4), anti-Klug et al. Genome Biology 2010, 11:R63
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trimethyl-histone H3 (Lys4), anti-acetyl-Histone H3,
anti-acetyl-Histone H4 or anti-IgG (07-030, 05-745, 06-
599, 06-866 or 12-370, respectively; Millipore, Schwal-
bach/Ts., Germany). Before precipitation, protein A-Sep-
harose beads (GE Healthcare, Munich, Germany) were
treated with 2 μg sheared salmon sperm DNA for 1 h at
4°C. Immunocomplexes were then recovered by incuba-
tion for 2 h with the blocked beads at 4°C. After reverse
cross-linking, DNA was purified using the QIAquick
PCR purification kit (Qiagen) according to the manufac-
turer's instructions except that the samples were incu-
bated with phosphate buffer for 30 minutes and that they
were eluted with 100 μl elution buffer. Enrichment of spe-
cific DNA fragments in the immunoprecipitated material
was determined by quantitative PCR on the Realplex
Mastercycler using the Quantifast SYBR Green PCR Kit
(Qiagen). Oligonucleotide sequences are given in Addi-
tional file 4.
Methyl-CpG immunoprecipitation
Production of the recombinant MBD-Fc protein and
MCIp were carried out as previously described [26,27]
with modifications. Briefly, genomic DNA of DCs and
macrophages was sonicated to a mean fragment size of
350 to 400 bp using a Branson Sonifier 250. Four micro-
grams of each sample were rotated with 200 μl protein A-
Sepharose 4 Fast Flow beads (GE Healthcare) coated with
70 μg purified MBD-Fc protein in 2 ml Ultrafree-MC
centrifugal devices (Millipore) for 3 h at 4°C in a buffer
containing 250 mM NaCl (buffer A). Beads were centri-
fuged to recover unbound DNA fragments (250 mM frac-
tion) and subsequently washed with buffers containing
increasing NaCl concentrations (300, 350, 400, 450, 500
mM; buffers B to F). Densely CpG-methylated DNA was
eluted with 1,000 mM NaCl (buffer G) and all fractions
were desalted using the QIAquick PCR Purification Kit
(Qiagen). The separation of CpG methylation densities of
individual MCIp fractions was controlled by quantitative
PCR using primers covering the imprinted SNRPN and a
region lacking CpGs (Empty), respectively. Fractions con-
taining unmethylated DNA (250 to 350 mM NaCl) or
methylated DNA (400 to 1,000 mM NaCl) fractions were
pooled before subsequent labeling.
Promoter microarray handling and analysis
Unmethylated (CpG) and methylated (mCpG) pools of
both cell types were labeled with Alexa Fluor 5-dCTP
(DCs) and Alexa Flour 3-dCTP (macrophages) using the
BioPrime Total Genomic Labeling System (Invitrogen) as
indicated by the manufacturer. Hybridization on 244K
Custom-Oligonucleotide-Microarrays (containing about
17,000 promoter regions (-4,000 to + 1,000 bp relative to
the TSS) as well as few regions tiled over large genomic
intervals)) and washing was performed as recommended
by the manufacturer (Agilent). Images were scanned
immediately using a DNA microarray scanner (Agilent)
and processed using Feature Extraction Software 9.5.1
(Agilent) with a standard comparative genomic hybrid-
ization protocol (including linear normalization). Pro-
cessed signal intensities were then imported into Excel
2007 for further analysis. Probes with abnormal hybrid-
ization behavior (extremely high or extremely low signal
intensities in one of the channels) were excluded. To
detect DMRs, log10 ratios of individual probes from both
comparative genome pool hybridizations were sub-
tracted. A more detailed description of the global methy-
lation assay (MCIp and hybridization) is given in [28].
Microarray data have been submitted and are available
from the NCBI GEO repository (accession number
[GEO:GSE19395]).
Mass spectrometry analysis of bisulfite-converted DNA
We chose a set of genomic regions based on the MCIp
microarray results and designed 48 amplicons for
bisulfite conversion. Genomic sequences were extracted
from the UCSC genome browser [49] and PCR primers
were designed using the Epidesigner web tool [50]. For
each reverse primer, an additional T7 promoter tag for in
vitro transcription was added, as well as a 10-mer tag on
the forward primer to adjust for melting temperature dif-
ferences. All primers were purchased from Sigma-
Aldrich (Munich, Germany; for sequences see Additional
file 2). Sodium bisulfite conversion was performed using
the EZ DNA Methylation Kit (Zymo Research, Orange,
CA, USA) with 1 μg of genomic DNA and an alternative
conversion protocol (Sequenom, San Diego, CA, USA).
Amplification of target regions was followed by treatment
with shrimp alkaline phosphatase, reverse transcription
and subsequent RNA base-specific cleavage (Mass-
CLEAVE, Sequenom) as previously described [38]. Cleav-
age products were loaded onto silicon chips
(spectroCHIP, Sequenom) and analyzed by MALDI-TOF
MS (MassARRAY Compact MALDI-TOF, Sequenom).
Methylation was quantified from mass spectra using the
Epityper software v1.0 (Sequenom). Methylation ratios
for all samples are given in Additional file 3
Proliferation assay
Proliferation capacity of cells was measured using [3H]-
thymidine incorporation. Cells were seeded in 96-well
microtiter plates and pulsed with 0.5 μCi [methyl-3H]-
thymidine per well (Hartmann Analytics, Braunschweig,
Germany) for 20 h. Cells were harvested onto UniFilter
plates using a Wallac harvester and incorporated [3H]-
thymidine was determined with a Wallac Betaplate coun-
ter (all from PerkinElmer, Gaithersburg, MD, USA).Klug et al. Genome Biology 2010, 11:R63
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Plasmid construction and transient DNA transfections
Differentially methylated regions (ranging from 800 to
1,000 bp) were PCR-amplified from human genomic
DNA and cloned into the CpG-free pCpGL-CMV/EF1
vector [32] by ligation replacing the cytomegalovirus
(CMV) enhancer with the DMRs. Primer sequences are
given in Additional file 4. Inserts were verified by
sequencing. Luciferase reporter constructs were either
mock-treated or methylated in vitro with SssI methylase
for 4 h at 37°C and purified with the Plasmid Quick Pure
Kit (Macherey-Nagel, Dueren, Germany) or using the
Endofree Plasmid Kit (Qiagen). THP-1 and HeLa cells
were transfected as described [51]. The transfected cells
were cultivated for 48 h and harvested. Cell lysates were
assayed for firefly and Renilla luciferase activity using the
Dual Luciferase Reporter Assay System (Promega, Man-
nheim, Germany) on a Lumat LB9501 (Berthold Detec-
tion Systems GmbH, Pforzheim, Germany). Firefly
luciferase activity of individual transfections was normal-
ized against Renilla luciferase activity.
Additional material
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